OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Improvement of adjunctive berberine treatment on negative symptoms in patients with schizophrenia
Meijuan Li, Yuying Qiu, Jing Zhang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 4, pp. 633-642
Closed Access | Times Cited: 12
Meijuan Li, Yuying Qiu, Jing Zhang, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 4, pp. 633-642
Closed Access | Times Cited: 12
Showing 12 citing articles:
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial
Thomas W. Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 191-200
Open Access | Times Cited: 12
Thomas W. Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Brain Behavior and Immunity (2023) Vol. 115, pp. 191-200
Open Access | Times Cited: 12
A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin
Ana María García-Muñoz, Desirée Victoria-Montesinos, Pura Ballester, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4576-4576
Open Access | Times Cited: 3
Ana María García-Muñoz, Desirée Victoria-Montesinos, Pura Ballester, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4576-4576
Open Access | Times Cited: 3
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials
Lorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 540-540
Open Access
Lorenzo Moccia, Francesca Bardi, Maria Benedetta Anesini, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 540-540
Open Access
The effects of selected phytochemicals on schizophrenia symptoms: A review
Melika Zamanian, Eric Gumpricht, Sepideh Salehabadi, et al.
Tissue and Cell (2025) Vol. 95, pp. 102911-102911
Closed Access
Melika Zamanian, Eric Gumpricht, Sepideh Salehabadi, et al.
Tissue and Cell (2025) Vol. 95, pp. 102911-102911
Closed Access
Berberine improves negative symptoms and cognitive function in patients with chronic schizophrenia via anti-inflammatory effect: a randomized clinical trial
Zhengping Pu, Hui‐Ju Wen, Hongxia Jiang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Zhengping Pu, Hui‐Ju Wen, Hongxia Jiang, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
Effects of berberine and barberry on selected inflammatory biomarkers in adults: A systematic review and dose–response meta‐analysis of randomized clinical trials
Yasaman Vahedi‐Mazdabadi, Hossein Shahinfar, Mohammad Toushih, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5541-5557
Closed Access | Times Cited: 7
Yasaman Vahedi‐Mazdabadi, Hossein Shahinfar, Mohammad Toushih, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5541-5557
Closed Access | Times Cited: 7
The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia
Xiaoxiao Sun, Guoshuai Luo, Xue Li, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 6, pp. 1365-1374
Closed Access | Times Cited: 5
Xiaoxiao Sun, Guoshuai Luo, Xue Li, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 6, pp. 1365-1374
Closed Access | Times Cited: 5
The Interrelationships between Cytokines and Schizophrenia: A Systematic Review
Haibing Lv, Meng Guo, Guo Chuang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8477-8477
Open Access | Times Cited: 1
Haibing Lv, Meng Guo, Guo Chuang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8477-8477
Open Access | Times Cited: 1
The associations between duration of untreated psychosis, growth factors, and neurocognition in patients with drug-naïve schizophrenia
Qiao Su, Zaimina Xuekelaiti, Hongyun Ma, et al.
Schizophrenia Research (2024) Vol. 274, pp. 113-120
Closed Access | Times Cited: 1
Qiao Su, Zaimina Xuekelaiti, Hongyun Ma, et al.
Schizophrenia Research (2024) Vol. 274, pp. 113-120
Closed Access | Times Cited: 1
Herbal Therapies for Weight Gain and Metabolic Abnormalities Induced by Atypical Antipsychotics: A Review Article
Hamideh Naghibi, Roshanak Salari, Mahdi Yousefi, et al.
Current Drug Discovery Technologies (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 3
Hamideh Naghibi, Roshanak Salari, Mahdi Yousefi, et al.
Current Drug Discovery Technologies (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 3
Network Pharmacology and Molecular Docking Analysis on Targets and Mechanisms of Berberine in Atypical Antipsychotic-Induced Metabolic Syndrome
Zhuowei Huang, Xiaolan Liu
Natural Product Communications (2022) Vol. 17, Iss. 10
Open Access | Times Cited: 2
Zhuowei Huang, Xiaolan Liu
Natural Product Communications (2022) Vol. 17, Iss. 10
Open Access | Times Cited: 2
